Related Experiment Video
Updated: Apr 28, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral annular disjunction and mitral valve prolapse: echocardiographic-MRI insights into cardiac function
Max D King1,2, Andrew C Peters3, Stuart Karimi4
1Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, 19104, USA. max.dallas.king1999@gmail.com.
Background:
Mitral annular disjunction (MAD) may accompany mitral valve prolapse (MVP) and is linked to ventricular arrhythmias. Its impact on global cardiac performance (specifically cardiac index (CI) and output (CO)), remains incompletely defined. Cardiac MRI (CMR) allows precise measurement of MAD, assessment of mitral annular dynamics, and detection of myocardial fibrosis via late gadolinium enhancement (LGE). We investigated both CMR and TTE metrics in patients with varying degrees of MAD compared to MVP-only.
Methods And Results:
Fifty-six patients who underwent CMR and TTE (mean age 61, 33 female) were divided into MAD ≥2 mm and MVP (the "MAD + MVP" group, n = 41) or MVP-only (n = 15). MAD was classified as <5 mm, ≥5 mm, and ≥ 10 mm in peak systole after excluding pseudo-MAD. LV volume, stroke volume, ejection fraction, cardiac output (CO), cardiac index (CI), mitral regurgitation (MR), and LGE were assessed. Any MAD was associated with lower CI versus MVP-only (p = 0.03). MAD ≥5 mm and MAD ≥ 10 mm showed reduced CO (p = 0.04 and 0.04, respectively) and CI (p = 0.04 and 0.03, respectively) versus MVP-only. LGE was more frequent in MAD ≥ 10 mm than in MAD < 10 mm (p = 0.028). MR incidence, volume, or fraction did not differ across groups. TTE showed agreement with CMR in MAD detection and quantification (p = 0.269), with minimal inter-observer variability (p < 0.001).
Conclusion:
MAD is associated with impaired cardiac performance independent of MR and with increased myocardial fibrosis in severe cases. These findings suggest heightened electromechanical stress in MAD compared to MVP-only, which needs to be clinically correlated. TTE reliably detects and quantifies MAD, supporting its use alongside CMR for assessment of MAD.
More Related Videos
12:12Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
11:50High-frequency High-resolution Echocardiography: First Evidence on Non-invasive Repeated Measure of Myocardial Strain, Contractility, and Mitral Regurgitation in the Ischemia-reperfused Murine Heart
Published on: July 9, 2010
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction